BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 7548129)

  • 1. The cationic lipid stearylamine reduces the permeability of the cationic drugs verapamil and prochlorperazine to lipid bilayers: implications for drug delivery.
    Webb MS; Wheeler JJ; Bally MB; Mayer LD
    Biochim Biophys Acta; 1995 Sep; 1238(2):147-55. PubMed ID: 7548129
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reversal of multidrug resistance in human colon cancer cells expressing the human MDR1 gene by liposomes in combination with monoclonal antibody or verapamil.
    Sela S; Husain SR; Pearson JW; Longo DL; Rahman A
    J Natl Cancer Inst; 1995 Jan; 87(2):123-8. PubMed ID: 7707383
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of charge and size on the interaction of unilamellar liposomes with macrophages.
    Schwendener RA; Lagocki PA; Rahman YE
    Biochim Biophys Acta; 1984 Apr; 772(1):93-101. PubMed ID: 6712952
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of DMPC and DSPC lipids for verapamil and naproxen permeability studies by PAMPA.
    Alvarez-Figueroa MJ; Contreras-Garrido BC; Soto-Arriaza MA
    Drug Dev Ind Pharm; 2015 Apr; 41(4):658-62. PubMed ID: 24568608
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The importance of cholesterol in maintenance of P-glycoprotein activity and its membrane perturbing influence.
    Rothnie A; Theron D; Soceneantu L; Martin C; Traikia M; Berridge G; Higgins CF; Devaux PF; Callaghan R
    Eur Biophys J; 2001 Oct; 30(6):430-42. PubMed ID: 11718296
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intrinsic resistance to chemotherapeutic agents in murine osteosarcoma cells.
    Takeshita H; Kusuzaki K; Ashihara T; Gebhardt MC; Mankin HJ; Hirasawa Y
    J Bone Joint Surg Am; 2000 Jul; 82-A(7):963-9. PubMed ID: 10901311
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improved retention of idarubicin after intravenous injection obtained for cholesterol-free liposomes.
    Dos Santos N; Mayer LD; Abraham SA; Gallagher RC; Cox KA; Tardi PG; Bally MB
    Biochim Biophys Acta; 2002 Apr; 1561(2):188-201. PubMed ID: 11997119
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of pH and intraliposomal buffer strength on the rate of liposome content release and intracellular drug delivery.
    Lee RJ; Wang S; Turk MJ; Low PS
    Biosci Rep; 1998 Apr; 18(2):69-78. PubMed ID: 9743475
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cationic phospholiposomes: efficient delivery vehicles of anticancer derivatives of ATP to multiple myeloma cells.
    Wang L; MacDonald RC
    J Liposome Res; 2011 Dec; 21(4):306-14. PubMed ID: 21457078
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A simple passive equilibration method for loading carboplatin into pre-formed liposomes incubated with ethanol as a temperature dependent permeability enhancer.
    Wehbe M; Malhotra A; Anantha M; Roosendaal J; Leung AWY; Plackett D; Edwards K; Gilabert-Oriol R; Bally MB
    J Control Release; 2017 Apr; 252():50-61. PubMed ID: 28286316
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transmembrane gradient driven phase transitions within vesicles: lessons for drug delivery.
    Lasic DD; Ceh B; Stuart MC; Guo L; Frederik PM; Barenholz Y
    Biochim Biophys Acta; 1995 Nov; 1239(2):145-56. PubMed ID: 7488619
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reversal of multidrug resistance by transferrin-conjugated liposomes co-encapsulating doxorubicin and verapamil.
    Wu J; Lu Y; Lee A; Pan X; Yang X; Zhao X; Lee RJ
    J Pharm Pharm Sci; 2007; 10(3):350-7. PubMed ID: 17727798
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liposomal delivery of hydrophobic weak acids: enhancement of drug retention using a high intraliposomal pH.
    Joguparthi V; Anderson BD
    J Pharm Sci; 2008 Jan; 97(1):433-54. PubMed ID: 17918731
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction of positively-charged liposomes with blood: implications for their application in vivo.
    Senior JH; Trimble KR; Maskiewicz R
    Biochim Biophys Acta; 1991 Nov; 1070(1):173-9. PubMed ID: 1751523
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of drug release from liposomal formulations in ocular fluid.
    Jafari MR; Jones AB; Hikal AH; Williamson JS; Wyandt CM
    Drug Deliv; 1998; 5(4):227-38. PubMed ID: 19569989
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pyranine as a sensitive pH probe for liposome interiors and surfaces. pH gradients across phospholipid vesicles.
    Kano K; Fendler JH
    Biochim Biophys Acta; 1978 May; 509(2):289-99. PubMed ID: 26400
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effective-Loading of Platinum-Chloroquine into PEGylated Neutral and Cationic Liposomes as a Drug Delivery System for Resistant Malaria Parasites.
    Ibrahim S; Tagami T; Ozeki T
    Biol Pharm Bull; 2017; 40(6):815-823. PubMed ID: 28566625
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of liposomal systems containing doxorubicin entrapped in response to pH gradients.
    Mayer LD; Tai LC; Bally MB; Mitilenes GN; Ginsberg RS; Cullis PR
    Biochim Biophys Acta; 1990 Jun; 1025(2):143-51. PubMed ID: 2364073
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytolytic activity of liposomes containing stearylamine.
    Yoshihara E; Nakae T
    Biochim Biophys Acta; 1986 Jan; 854(1):93-101. PubMed ID: 3942721
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of calcitonin-containing liposome formulations for intranasal delivery.
    Law SL; Shih CL
    J Microencapsul; 2001; 18(2):211-21. PubMed ID: 11253938
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.